Managers / Q4 2021 · view latest →
Avoro Capital Advisors LLC
CIK 0001633313 · 110 GREENE STREET, SUITE 800, NEW YORK, NY, 10012 · 212-937-4975
Reported Value
$5.9B
Q4 2021
Positions
41
Filings on Record
31
2019–present window
Filed
Feb 14, 2022
original filing
Summary
Avoro Capital Advisors Llc reported $5.9B in U.S.-listed holdings across 41 positions for Q4 2021.
Its largest position, Horizon Therapeutics, represents 17.0% of the portfolio.
Compared with Q3 2021, the fund opened 3 new positions and exited 6.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 68.5% · $4.0B
- Other · 23.8% · $1.4B
- ADR · 5.8% · $338M
- ETP · 2.0% · $118M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q4 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $10.2B | 33 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $10.2B | 34 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $7.7B | 32 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $5.7B | 30 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $6.4B | 33 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $7.1B | 39 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $6.9B | 36 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $7.5B | 41 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $8.6B | 46 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $7.2B | 42 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $6.4B | 46 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $7.4B | 43 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $6.7B | 41 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $6.69T | 36 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $5.4B | 39 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $5.1B | 40 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $5.5B | 43 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $5.9B | 41 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $6.4B | 52 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $5.7B | 46 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $5.8B | 46 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $5.8B | 44 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $7.0B | 46 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $5.1B | 45 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $3.0B | 43 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $3.4B | 32 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $2.4B | 33 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $2.9B | 35 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $2.3B | 32 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $1.7B | 35 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.